Literature DB >> 30216863

Increases in orbitofrontal cortex thickness following antidepressant treatment are associated with changes in resting state autonomic function in adolescents with major depression - Preliminary findings from a pilot study.

Julian Koenig1, Melinda Westlund Schreiner2, Bonnie Klimes-Dougan2, Benjamin Ubani3, Bryon A Mueller3, Kelvin O Lim3, Michael Kaess4, Kathryn R Cullen5.   

Abstract

In adults with major depressive disorder (MDD), effective treatment has been associated with increases in both heart rate variability (HRV) and cortical thickness. However, the impact of treatment on these indices has not yet been examined in adolescents. Cortical thickness and HRV were measured in twelve adolescents with MDD before and after 8 weeks of treatment with a selective serotonin reuptake inhibitor (SSRI). We examined treatment-related changes in depression symptoms, HRV, heart rate (HR), and cortical thickness, and analyzed correlations among these change indices. At follow-up, patients showed significantly decreased depression severity, increased HRV and increased thickness of the left medial orbitofrontal cortex (OFC). Clinical improvement was associated with increased HRV and decreased HR. Increased HRV was associated with increased cortical thickness of left lateral OFC and superior frontal cortex. Due to the small sample size, results represent preliminary findings that need replication. Further, in the absence of a placebo arm, we cannot confirm that the observed effects are due solely to medication. These preliminary findings suggest that SSRI treatment in adolescents impacts both cortical thickness and autonomic functioning. Confirmation of these findings would support OFC thickness and HRV as neurobiological mediators of treatment outcome.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Adolescent; Cortical thickness; Depression; Heart rate; Heart rate variability; Longitudinal; Treatment

Mesh:

Substances:

Year:  2018        PMID: 30216863      PMCID: PMC6204080          DOI: 10.1016/j.pscychresns.2018.08.013

Source DB:  PubMed          Journal:  Psychiatry Res Neuroimaging        ISSN: 0925-4927            Impact factor:   2.376


  55 in total

1.  Right anterior cingulate cortical volume covaries with respiratory sinus arrhythmia magnitude in combat veterans.

Authors:  Steven H Woodward; Danny G Kaloupek; Marie Schaer; Christelle Martinez; Stephan Eliez
Journal:  J Rehabil Res Dev       Date:  2008

Review 2.  Autonomic dysfunction and heart rate variability in depression.

Authors:  Andrea Sgoifo; Luca Carnevali; Maria de los Angeles Pico Alfonso; Mario Amore
Journal:  Stress       Date:  2015-05-25       Impact factor: 3.493

3.  Statistical considerations for reporting and planning heart rate variability case-control studies.

Authors:  Daniel S Quintana
Journal:  Psychophysiology       Date:  2016-12-03       Impact factor: 4.016

Review 4.  The neuroscience of depression: implications for assessment and intervention.

Authors:  Manpreet K Singh; Ian H Gotlib
Journal:  Behav Res Ther       Date:  2014-09-04

5.  Abnormal amygdala resting-state functional connectivity in adolescent depression.

Authors:  Kathryn R Cullen; Melinda K Westlund; Bonnie Klimes-Dougan; Bryon A Mueller; Alaa Houri; Lynn E Eberly; Kelvin O Lim
Journal:  JAMA Psychiatry       Date:  2014-10       Impact factor: 21.596

6.  Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement.

Authors:  Alexander H Glassman; J Thomas Bigger; Michael Gaffney; Louis T Van Zyl
Journal:  Arch Gen Psychiatry       Date:  2007-09

7.  Increases in heart rate variability with successful treatment in patients with major depressive disorder.

Authors:  S Balogh; D F Fitzpatrick; S E Hendricks; S R Paige
Journal:  Psychopharmacol Bull       Date:  1993

8.  How heart rate variability affects emotion regulation brain networks.

Authors:  Mara Mather; Julian Thayer
Journal:  Curr Opin Behav Sci       Date:  2018-02

Review 9.  Brain Structural Effects of Antidepressant Treatment in Major Depression.

Authors:  Nicola Dusi; Stefano Barlati; Antonio Vita; Paolo Brambilla
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

Review 10.  Brain Functional Effects of Psychopharmacological Treatment in Major Depression: a Focus on Neural Circuitry of Affective Processing.

Authors:  Michèle Wessa; Giannis Lois
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

View more
  5 in total

1.  Insular Cortical Thickness in Patients With Somatoform Pain Disorder: Are There Associations With Symptom Severity and Childhood Trauma?

Authors:  Elisabeth Meyer; Eva Morawa; Yeliz Nacak; Julie Rösch; Arnd Doerfler; Clemens Forster; Yesim Erim
Journal:  Front Psychiatry       Date:  2020-09-10       Impact factor: 4.157

2.  Effects of acute transcutaneous vagus nerve stimulation on emotion recognition in adolescent depression.

Authors:  Julian Koenig; Peter Parzer; Niklas Haigis; Jasmin Liebemann; Tamara Jung; Franz Resch; Michael Kaess
Journal:  Psychol Med       Date:  2019-12-10       Impact factor: 7.723

Review 3.  Psychedelics and Other Psychoplastogens for Treating Mental Illness.

Authors:  Maxemiliano V Vargas; Retsina Meyer; Arabo A Avanes; Mark Rus; David E Olson
Journal:  Front Psychiatry       Date:  2021-10-04       Impact factor: 4.157

4.  Respiratory-gated auricular vagal afferent nerve stimulation (RAVANS) modulates brain response to stress in major depression.

Authors:  Ronald G Garcia; Justine E Cohen; Arielle D Stanford; Aileen Gabriel; Jessica Stowell; Harlyn Aizley; Riccardo Barbieri; David Gitlin; Vitaly Napadow; Jill M Goldstein
Journal:  J Psychiatr Res       Date:  2021-08-02       Impact factor: 5.250

5.  Cortical Thickness Predicts Response Following 2 Weeks of SSRI Regimen in First-Episode, Drug-Naive Major Depressive Disorder: An MRI Study.

Authors:  Peiyi Wu; Aixia Zhang; Ning Sun; Lei Lei; Penghong Liu; Yikun Wang; Hejun Li; Chunxia Yang; Kerang Zhang
Journal:  Front Psychiatry       Date:  2022-02-22       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.